Clincosm LogoSign in Get a demo

Ovarian Carcinoma

Showing 26 - 50 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in United States (STRO-002, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Tampa, Florida
  • +5 more
Aug 1, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Santa Monica, California
  • +4 more
Jul 26, 2022

Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,

Recruiting
  • Ovarian Cancer
  • +13 more
  • Mind-body resilience training
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Jun 28, 2022

Ovarian Carcinoma Trial in Houston (dietary supplement, other, behavioral)

Active, not recruiting
  • Ovarian Carcinoma
  • Dietary Intervention
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 23, 2022

Factors Influencing Cascade Testing Among Hereditary

Recruiting
  • Breast Carcinoma
  • +8 more
  • Interview
  • +2 more
  • Birmingham, Alabama
  • +1 more
Jun 22, 2022

Ovarian Cancer, Ovarian Carcinoma Trial in United States (Intravenous Indocyanine Green/ICG injection, PINPOINT endoscopic

Recruiting
  • Ovarian Cancer
  • Ovarian Carcinoma
  • Intravenous Indocyanine Green/ICG injection
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jun 21, 2022

Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)

Terminated
Has Results
  • Ovarian Carcinoma
  • Denosumab
  • Salpingo-Oophorectomy
  • Boston, Massachusetts
  • +5 more
May 23, 2022

Ovarian Carcinoma Trial (Presence of sarcopenia evaluated prior to neoadjuvant chemo and during chemo as part of optimised

Not yet recruiting
  • Ovarian Carcinoma
  • Presence of sarcopenia evaluated prior to neoadjuvant chemotherapy and during chemotherapy as part of optimised management(dietician and APA).
  • (no location specified)
Jun 10, 2022

Ovarian Carcinoma Trial in United States (Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy, Quality-of-Life

Recruiting
  • Ovarian Carcinoma
  • Bilateral Salpingectomy
  • +3 more
  • Birmingham, Alabama
  • +317 more
Jun 1, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV Trial in Boston (Exercise, Attention Control)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Exercise
  • Attention Control
  • Boston, Massachusetts
    Dana Farber Cancer Institute
May 4, 2022

Ovarian Carcinoma Trial (Paclitaxel, Carboplatin)

Completed
  • Ovarian Carcinoma
  • (no location specified)
Apr 7, 2022

Ovarian Carcinoma, Survival Outcomes, Adverse Events Trial in Beijing (Niraparib plus anlotinib)

Recruiting
  • Ovarian Carcinoma
  • +8 more
  • Niraparib plus anlotinib
  • Beijing, Beijing, China
    Lei Li
Apr 5, 2022

Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Beijing (Albumin-bound paclitaxel and

Recruiting
  • Ovarian Carcinoma
  • +6 more
  • Albumin-bound paclitaxel and bevacizumab
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Ovarian Carcinoma Trial in France (Experimental arm)

Active, not recruiting
  • Ovarian Carcinoma
  • Experimental arm
  • Dijon, Centre Georges François Leclerc, France
  • +6 more
Mar 29, 2022

NSCLC, SCLC, CRPC Trial in Tianjin (JAB-8263)

Recruiting
  • NSCLC
  • +7 more
  • Tianjin, Tianjin, China
    Tianjin
Mar 11, 2022

Breast Carcinoma, Cervical Carcinoma, Ovarian Carcinoma Trial in United States (Bupropion 150 mg XL, Placebo)

Completed
Has Results
  • Breast Carcinoma
  • +6 more
  • Bupropion 150 mg XL
  • Placebo
  • Anaheim, California
  • +361 more
Feb 10, 2022

Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma Trial in Duarte (Best Practice, Educational Intervention, Genomic

Recruiting
  • Breast Carcinoma
  • +6 more
  • Best Practice
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 11, 2022

Ovarian Carcinoma Trial in Evanston, Houston (other, procedure, behavioral)

Active, not recruiting
  • Ovarian Carcinoma
  • Ovarian Cancer Screening
  • +5 more
  • Evanston, Illinois
  • +1 more
Feb 3, 2022

Ovarian Cancer, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (TJ004309)

Recruiting
  • Ovarian Cancer
  • +5 more
  • Tucson, Arizona
  • +17 more
Jan 18, 2022

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

Breast Carcinoma, Colon Carcinoma, Malignant Solid Tumor Trial in Sequim (Electronic Health Record Review, Questionnaire

Completed
  • Breast Carcinoma
  • +5 more
  • Electronic Health Record Review
  • +2 more
  • Sequim, Washington
    Olympic Medical Cancer Center
Jan 4, 2022

Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Complications in Older Gynecologic Cancer Undergoing Surgery

Completed
  • Endometrial Serous Adenocarcinoma
  • +9 more
  • Comprehensive Geriatric Assessment
  • Questionnaire Administration
  • Birmingham, Alabama
  • +392 more
Nov 23, 2021